matchedPattern,context,lineNumber,columnNumber,publicationName
p.G193S,"mutation, p.G193S, causing fatal infanti...",289,11,Acta_Myol_2011_Jul_30(1)_9-15.txt
p.T378P,...eviously unreported mutation (p.T378P) that we had identifie...,98,294,Acta_Myol_2011_Oct_30(2)_96-102.txt
p.V600E,"...aneous melanomas (c.1799 T>A, p.V600E), raising the question...",3,2201,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,...ns were present in codon 209 (p.Gln209Pro and p.Gln209Leu) a...,81,162,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,...in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic ...,81,178,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"...ne BRAF mutation (c.1799 T>A, p.V600E), in a melanoma. No HR...",81,801,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,3	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,86,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,9	MC	c.626 A>C (p.Gln209Pro)	wt	na	wt,92,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,10	MM	c.626 A>T (p.Gln209Leu)	wt	wt	na,93,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,12	MC	c.626 A>T (p.Gln209Leu)	wt	na	na,95,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,13	MC	c.626 A>T (p.Gln209Leu)	wt	wt	na,96,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,14	MC	c.626 A>T (p.Gln209Leu)	wt	wt	wt,97,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,15	MM	wt	c.1799 T>A (p.V600E)	na	wt,98,22,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"...utation (case 15; c.1799 T>A, p.V600E) might be a metastasis...",114,857,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Val600Glu,...Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mu...,152,68,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Val600Lys,...dence of BRAF p.Val600Glu and p.Val600Lys mutations in a con...,152,84,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.V600E,... F Capper D Detection of BRAF p.V600E mutations in melanomas...,162,128,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Tyr1858Sto,...From birth	ex45; c.5574C > G; p.Tyr1858Stop; int122; c.19101...,36,326,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Tyr4356Thr,...licated region); c.13066delT; p.Tyr4356Thrfs*8 ex110; c.1753...,39,327,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu5845Glu,...6Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu	exon 86: frameshi...,39,365,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu8229Glu,...irth	ex177; c.24686_24687del; p.Glu8229Glufs*18	both mutatio...,40,352,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Arg7807Ser,ex163; c.23420_23421del; p.Arg7807Serfs*16,41,26,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu8229Glu,...irth	ex177; c.24686_24687del; p.Glu8229Glufs*18	both mutatio...,42,360,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Arg7807Ser,ex163; c.23420_23421del; p.Arg7807Serfs*16,43,26,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Gly6976Gly,... 1 month	ex139; c.20928G > T; p.Gly6976Gly	RTPCR and Sanger ...,46,389,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Pro8148Ser,"... ex174; c.24440_24441insGTCA, p.Pro8148Serfs*15	truncating/d...",48,390,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Val7425Ser,..._Thr1778del ex153; c.22273del p.Val7425Serfs49*	intron 43: a...,49,380,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ser8193Ser,"...tion.	No	ex175; c.24579G > A, p.Ser8193Ser ex119; c.18676C >...",50,383,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Gln6226*,"...r8193Ser ex119; c.18676C > T, p.Gln6226*	ex175: a splice sit...",50,417,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Val3348Ala,"...n.	No	ex69; c.10043_10046del, p.Val3348Alafs *43 ex49; c.638...",52,285,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ala2130Pro,...48Alafs *43 ex49; c.6388G > C p.Ala2130Pro	ex69: truncating/...,52,322,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ala8203Gln,ex176; c.24606del p.Ala8203Glnfs*13,55,19,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.V600E,"...he group I tumors, and a BRAF:p.V600E mutation in 43% of gro...",7,753,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...ns are found in PAs, and BRAF:p.V600E mutations are frequent...",17,414,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,... in PXAs (~70%) [14-19]. BRAF:p.V600E mutations are also pre...,17,485,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF:p.V600E mutations were detecte...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...RN1 and GNAI1[17,19,21]. BRAF:p.V600E mutations occur in PXA...",133,512,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,... KIAA1549-BRAF fusion or BRAF:p.V600E mutation. Low-grade ne...,133,925,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.R132H,...ldhood rarely contain an IDH1:p.R132H mutation. This mutatio...,133,1023,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,... KIAA1549-BRAF fusion or BRAF:p.V600E mutation [27],133,1448,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...anglioglioma, harbored a BRAF:p.V600E mutation. This mutatio...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.Phe93Leu,"...e mutation [1, 2], c.279C > G p.Phe93Leu in patient 3s. Pati...",118,117,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe91Ile,"... novel mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.P...",118,194,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe91Leu,"... A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectively, affe...",118,221,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.K510E,...ases with the newly described p.K510E mutation and a case wi...,5,897,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,... and a case with both a known p.P525L mutation in the FUS ge...,5,943,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...the FUS gene and a truncating p.Y374X mutation in the TARDBP...,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...tion. Case 6 harboured both a p.P525L FUS mutation and also ...,34,627,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...US mutation and also a TARDBP p.Y374X truncation mutation, t...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...o test for segregation of the p.P525L and p.Y374X mutations,...",34,906,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...egregation of the p.P525L and p.Y374X mutations, however, cl...",34,918,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,2	14	c.1528A>G	p.K510E	39	M	15	Yes	Yes	B	No,38,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,17,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,15	c.1574C>T	p.P525L,43,15,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...arried a previously described p.Y374X TARDBP mutation (cDNA ...,49,45,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...d neurons (arrows) in case 5 (p.R521H). H&E. b Well circumsc...,121,136,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...terior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mut...,121,239,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This...,121,251,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...ike inclusions (inset-case 2 (p.K510E)) which resemble conde...,121,389,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,...s of the spinal cord. Case 1 (p.R495X). Anti p62. d-f. Revea...,121,582,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,"...the spinal cords in case 1 (d-p.R495X), case 2 (e-p.K510E), ...",121,756,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,"...case 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521...",121,776,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"... 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale Bar ...",121,800,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...of the spinal cord in case 2 (p.K510E) with remnants of FUS ...,124,89,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...tivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mut...,124,159,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also ...,124,171,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,... inset. f The cord in case 1 (p.R495X) revealing very mild l...,124,807,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mut...,126,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) a...,126,28,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"... illustrated 2 cases with the p.P525L mutation, one of whom ...",135,1549,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510M,...ed-in state associated with a p.K510M mutation and abundant ...,135,2417,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,... this time in patients with a p.R521C mutation which is iden...,135,2612,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...sions (including 2 cases with p.P525L mutations) tended to h...,135,3215,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,...ssion (including 2 cases with p.R521C mutations). Our findin...,135,3462,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...ouping. Whereas case 5 with a p.R521H mutation would certain...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...t in the cord. Case 6 (with a p.P525L mutation) also had mod...,135,4214,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...s patient as well as having a p.P525L mutation also had a tr...,135,4494,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...utation also had a truncating p.Y374X TARDBP mutation on chr...,135,4533,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...described the genetics of the p.Y374X TARDBP mutation and ha...,135,5525,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...ith ALS-FUS associated with a p.K510E mutation. Syriani et a...,137,107,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,The p.R514G missense mutation agai...,139,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510M,...tient with familial ALS and a p.K510M mutation in the gene f...,184,150,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.N352S,...rophic lateral sclerosis with p.N352S mutation in TARDBP Neu...,187,179,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.A31P,...Maine Coon cats caused by the p.A31P cMyBP-C mutation - the ...,3,196,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... for a proline at residue 31 (p.A31P) of cMyBP-C. The patter...,4,263,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ygous or heterozygous for the p.A31P cMyBP-C mutation in you...,4,704,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...al swabs and screened for the p.A31P cMyBP-C mutation in exo...,7,197,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...us for the mutation had fHCM. p.A31P heterozygosity was not ...,10,360,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... that develop fHCM due to the p.A31P mutation prior to the a...,13,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... for a proline at residue 31 (p.A31P) of the cMyBP-C protein...,22,217,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...zygous and homozygous for the p.A31P cMyBP-C mutation in a l...,24,126,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The p.A31P cMyBP-C genotype of all...,32,5,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... clinical significance of the p.A31P cMyBP-C protein mutatio...,38,185,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cy to an increasing effect of p.A31P cMyBP-C homozygosity wi...,44,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...as only a low effect of being p.A31P cMyBP-C heterozygous, ρ...",44,391,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... of tendency. Green indicates p.A31P cMyBP-C heterozygous co...,44,708,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...e of tendency. Blue indicates p.A31P cMyBP-C homozygous wher...,44,803,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...HCM clinical presentation and p.A31P cMyBP-C, respectively",48,417,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value mutati...,73,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...M positive cats in respect to p.A31P genotype,97,99,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value,107,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,p.A31P cMyBP-C genotypin,132,1,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...equivocal cases in respect to p.A31P cMyBP-C genotype status...,135,66,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...e entire cohort. The group of p.A31P cMyBP-C homozygous cats...,135,167,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The significance of the p.A31P cMyBP-C mutatio,139,25,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...us and homozygous carriers of p.A31P cMyBP-C between fHCM af...,140,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...lassified as equivocal. Among p.A31P cMyBP-C homozygous MC c...,142,145,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...LVFW as a function of age and p.A31P cMyBP-C heterozygous or...,157,116,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ance of being affected by the p.A31P cMyBP-C mutation in mid...,159,172,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cal cats as a function of the p.A31P cMyBP-C genotype is sho...,159,911,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ozygous or homozygous for the p.A31P cMyBP-C mutation in a c...,162,87,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...dency to progress with age in p.A31P cMyBP-C homozygous cats...,164,92,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...gnificant association between p.A31P cMyBP-C and fHCM was fo...,166,314,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ts. This again indicated that p.A31P cMyBP-C associated fHCM...,166,396,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...mutation. We propose that the p.A31P cMyBP-C mutation result...,166,602,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...s et al. [11] stated that the p.A31P mutation is less pathog...,168,480,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... can not be excluded that the p.A31P cMyBP-C mutation may ex...,170,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ith cats heterozygous for the p.A31P mutation and affected w...,170,467,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... mutation is present with the p.A31P cMyBP-C mutation. Digen...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The p.A31P cMyBP-C genotype distri...,180,5,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...cats, which supports that the p.A31P cMyBP-C mutation was di...",180,270,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...prevalence of fHCM and of the p.A31P cMyBP-C mutation found ...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"In conclusion, p.A31P cMyBP-C associated fHCM...",183,16,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...upport the pathogenic role of p.A31P when two affected gene ...,183,156,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ity of developing fHCM in the p.A31P cMyBP-C homozygous cats...,183,556,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...s, although genotyping of the p.A31P cMyBP-C mutation can no...",183,678,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ner diameter; MC: Maine Coon; p.A31P: alanine substituted fo...,186,407,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.Thr328Lys,...nd men is associated with the p.Thr328Lys mutation in the F1...,168,169,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.txt
p.A53T,"...r the SNCA missense mutation, p.A53T [73]. A number of other...",59,313,Alzheimers_Res_Ther_2013_Jul_31_5(Suppl_1)_S7.txt
p.T185S,...ymous SNP numbered rs3173615 (p.T185S) located in exon 6 of ...,18,956,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...ion)	pTDP-43 immunoreactivity	p.T185S genotype,28,178,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"... and the hippocampus, and the p.T185S genotype of the rs3173...",55,454,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of t...,66,31,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...ing this, we investigated the p.T185S genotype of rs3173615 ...",89,243,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...h the coding rs3173615 SNP of p.T185S, is closely associated...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e linkage disequilibrium with p.T185S on rs3173615 [3,13,15]...",130,152,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,Showing p.T185S genotyping analysis. T...,150,9,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of t...,150,68,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...kson DW Rademakers R TMEM106B p.T185S regulates TMEM106B pro...,179,221,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.G130A,"...mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 20...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A242T,"...7,622	n/a	c.724G > A	1/97 (1)	p.A242T, conserveda",123,51,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.D255D,...s61734362	c.765C > T	1/97 (1)	p.D255D,125,58,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.P261P,...1042486	c.783G > C	46/97 (45)	p.P261P,126,59,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A339A,"...,603	n/a	c.1017C > G	1/97 (1)	p.A339A",127,52,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala242Thr,"...724G > A change, resulting in p.Ala242Thr. Though this is a ...",135,96,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Asn125Ser,"...utation in HESX1, c.374A > G (p.Asn125Ser). However, since t...",140,161,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala172Phe,...last Growth Factor Receptor 2 p.Ala172Phe Mutation in Pfeiff...,3,204,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...terozygous missense mutation, p.Ala172Phe, located in the Ig...",7,835,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Pro252Arg,"...a specific mutation in FGFR1, p.Pro252Arg can cause Pfeiffer...",14,295,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...c.514_515delGCinsTT, encoding p.Ala172Phe) and was previousl...",16,795,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...c.514_515delGCinsTT, encoding p.Ala172Phe. This sequence cha...",33,429,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...p allele, suggesting that the p.Ala172Phe mutation had arise...",37,675,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...has also been implicated. The p.Ala172Phe mutation, involvin...",40,462,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,...phenotype associated with the p.Ala172Phe mutation is atypic...,42,76,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,... a more severe feature of the p.Ala172Phe mutation than most...,42,1762,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...re limb) correlation with the p.Ala172Phe mutation, both wit...",42,2474,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...tor–receptor contacts. In the p.Ala172Phe mutation, substitu...",71,807,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,...r syndrome resulting from the p.Ala172Phe mutation is infreq...,75,53,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.W299R,...	M	6/12	6/12	23.16	22.92	RGS9	p.W299R / p.R128X	MCW,93,41,Am_J_Ophthalmol_2015_Dec_160(6)_1269-1275_e1.txt
p.R128X,...12	23.16	22.92	RGS9	p.W299R / p.R128X	MCW,93,51,Am_J_Ophthalmol_2015_Dec_160(6)_1269-1275_e1.txt
p.Arg110*,"...emature stop codon (c.328C>T, p.Arg110*) and a donor splice‐...",42,228,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,...premature translational stop (p.Arg110*) at position chr22: ...,80,706,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,"... translational stop c.328C>T, p.Arg110* at genomic position ...",82,275,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,"...TF nonsense variant c.328C>T, p.Arg110* (chr22: 32 322 242a)...",88,69,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Ile442Met,...nit G (NCAPG) gene encoding a p.Ile442Met variant is associa...,1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Gln1124*,...NA revealing homozygosity for p.Gln1124*. The DST gene encod...,18,219,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg1249*,...econd mutation identified was p.Arg1249*. It was reported in...,18,493,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Gln1124*,"...ll shown to be homozygous for p.Gln1124*, the mutation that ...",18,855,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro1929Leu,"...meshift mutation, c.5786delC (p.Pro1929Leufs*8). Then, two E...",33,188,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Phe466Leu,... German case were c.1395delC (p.Phe466Leufs*44) and c.2897de...,33,364,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro966Leu,"...e466Leufs*44) and c.2897delC (p.Pro966Leufs*11), whereas in ...",33,398,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro649Pro,...tations comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>...,33,481,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ser750*,...ro649Profs*11) and c.2249C>A (p.Ser750*). The most recently ...,33,514,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Leu1217*,... homozygosity for c.3650T> A (p.Leu1217*). All pathogenic mu...,33,612,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro392Val,"...ift mutation, c.1173_1174del (p.Pro392Valfs*2). The second c...",48,306,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg628Pro,"...missense mutation, c.1883G>C (p.Arg628Pro) that occurred wit...",48,491,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the m...",48,781,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ala349Ser,"...ous effects of the mutations (p.Ala349Ser, c.1538-1G>A, and ...",51,1428,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin st...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Y279N,"...vel homozygous, c. 835 T > A (p.Y279N) mutation in exon 6 in...",3,1589,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Y279N,... novel mutation c. 835 T > A (p.Y279N) in exon 6,37,129,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Arg438Cys,"...thogenic mutation, c.1312C>T (p.Arg438Cys), was identified. ...",3,1972,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Arg438Cys,...hange in the protein level of p.Arg438Cys (Fig. 2). Mutation...,17,547,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Arg632Gln,...ameshift mutation (c.1893dup; p.Arg632Glnfs*20). To our know...,3,1938,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...ameshift mutation (c.1893dup; p.Arg632Glnfs*20) in the proba...,21,204,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...ameshift mutation (c.1893dup; p.Arg632Glnfs*20) but neither ...,21,457,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...ameshift mutation (c.1893dup; p.Arg632Glnfs*20) leads to a p...,26,819,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...ameshift mutation (c.1893dup; p.Arg632Glnfs*20) in the proba...,41,75,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Glu255Lys,... [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly detect...,15,772,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.Glu255Lys,... to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,501,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.G296S,...n KCNQ4 pore-region mutation (p.G296S) causes deafness by im...,150,98,Appl_Clin_Genet_2012_Oct_18_5_97-104.txt
p.Arg1256X,"...G (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaff...",18,405,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.Arg1150X,"...nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were...",18,913,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.D630Y,"...3B1). The mutation (c.G1888T, p.D630Y) lies in the Y-domain ...",41,346,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.D630Y,... target of GNA11/GNAQ and the p.D630Y PLCB4 mutation was mut...,41,602,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.Asp411Val,...don: c.1232_1234delinsTTTGAA (p.Asp411Valfs*2). No pathogeni...,53,48,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,(p.Asp411Valfs*2) in the KCNH2 ...,109,2,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,... This analysis classified the p.Asp411Valfs*2 mutatio,114,64,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Cys,...ed that in-vitro mutagenesis (p.Asp411Cys) resulting i,119,62,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,...he pathogenicity of the novel p.Asp411Valfs*2 alteration,123,51,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.His161Arg,...se and analysis of the IL-17F p.His161Arg polymorphism in IB...,141,325,Arthritis_Res_Ther_2008_Apr_18_10(2)_206.txt
p.Gln4154Lys,"...gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of ...",3,1299,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...gene polymorphism c.12669G>A, p.Gln4154Lys and its relations...",3,1580,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in...",8,1395,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in n...",28,74,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Asp727Glu,"...d the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the h...",3,1433,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...27 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gen...",3,1446,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...e TSHR gene that contains the p.D727E polymorphism and diges...,3,1835,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...hese results suggest that the p.D727E polymorphism of the TS...,3,2354,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...er (MNG)Codon 727 polymorphismp.D727EThyroid-stimulating hor...,5,49,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Asp727Glu,...tamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the i...,8,1212,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...r aspartic acid (p.Asp727Glu; p.D727E) in the intracellular ...,8,1225,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ic MNG, the expression of the p.D727E variant in eukaryotic ...",8,1351,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ased cAMP accumulation. Thus, p.D727E could induce growth an...",8,1578,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...tigated the frequency of this p.D727E polymorphism in Turkis...,8,1681,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...e TSHR gene that contains the p.D727E polymorphism (rs199151...,17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"... and control group, while the p.D727E polymorphism is signif...",26,551,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,We screened the p.D727E polymorphism of the TS...,29,17,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...rect relationship between the p.D727E polymorphism and non t...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"... Clearly, the presence of the p.D727E polymorphism in the TS...",29,260,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...el et al.[1] indicated that a p.D727E polymorphism of the hu...,31,36,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...he heterozygous state for the p.D727E polymorphism of the TS...,31,363,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...frequency of the polymorphism p.D727E in a large group of pa...,33,192,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...nsideration the fact that the p.D727E TSHR variant is freque...,35,60,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...his is the first study of the p.D727E polymorphism in Turkis...,35,466,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...G. According to our data, the p.D727E variant is frequently ...",35,544,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...d restriction analysis of the p.D727E polymorphisms of the T...,37,52,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ble 3 The distribution of the p.D727E genotypes and allelic ...,68,33,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.G130V,...ce for the correlation of the p.G130V mutation in the GJB2 g...,163,178,Biochem_J_2010_Aug_1_429(Pt_3)_473-483.txt
p.Trp400Val,"... delTG, Q00536-2 (isoform 2): p.Trp400ValfsVPAP]. This resul...",91,589,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.Arg488Ter,"...497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (http://genetics....",91,924,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.L849P,"... L860P [14,15] referred to as p.L849P in these publications ...",33,78,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,... R1827X ([15]; referred to as p.R1816X therein) were introdu...,33,172,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,...nus at position Arg1827 (also p.R1816X in [15]; Fig. 1a) was...,52,57,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.Leu849Pro,"...line residue replaced Leu860 (p.Leu849Pro in [14,15]). The L...",56,73,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.Val220Ile,...ady described c.658_659delGT (p.Val220Ilefs) mutation on BRC...,84,628,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,...usly unknown c.2944_2944delA (p.Ile982Tyrfs) mutation on BRC...,84,711,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,"... undescribed c.2944_2944delA (p.Ile982Tyrfs), occurs on BRCA...",114,607,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,... undescribed c.2944_2944delA (p.Ile982Tyrfs) mutation. Overa...,116,661,Biomark_Res_2015_Jun_6_3_13.txt
p.S34N,"...ficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, ...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.S34N,...Emingil G  Atilla G   A novel p.S34N mutation of CAMP gene i...,188,57,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.V600E, c.1799T>A	p.V600E	56 (29.9),189,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	11 (5.9),192,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1 (0.5),194,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	34 (18.2),196,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	5 (2.7),197,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	7 (3.7),199,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	6 (3.2),200,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.183G>T	p.Q61H	1 (0.5),201,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	8 (4.3),203,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.181C>A	p.Q61H	1 (0.5),204,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K	1 (0.5),205,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	6,246,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1,248,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	7,251,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	4,253,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	3,254,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	2,256,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K,257,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.R1441C,...Theuns J.    Founder mutation p.R1441C in the leucine-rich r...,127,63,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
p.R196P,23	1	−	+ (76%)	Exon 6/p.R196P,58,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,24	2	+ (86%)	−	Exon 8/p.R273H,59,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R175H,26	2	+ (70%)	−	Exon 5/p.R175H,61,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,27	2	+ (94%)	−	Exon 8/p.R273H,62,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R249S,29	2	+ (6%)	−	Exon 7/p.R249S,64,22,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.P142R,30	2	+ (53%)	−	Exon 5/p.P142R and exon 6/m.P222 L,66,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.Del264L,37	3	+ (17%)	−	Exon 8/p.Del264L,73,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.Gly646Trp,...frequent mutation (c.1934dupG;p.Gly646TrpfsX12) in virtually...,29,109,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.Gly646Trp,... ASH 2010 included c.1934dupG;p.Gly646TrpfsX12 as a true mut...,29,929,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.Gly646Trp,... variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a som...,189,112,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.R771Pfs,...cArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation PLo...,157,233,BMC_Biochem_2011_Nov_4_12_57.txt
p.G12V,...S codon 12 mutation (c.35G>T; p.G12V) was detected in the py...,7,900,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...at exon 1, codon 12 (c.35G>T; p.G12V) and wildtype sequence ...",55,100,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12R,"...ostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,172,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains a...",96,152,BMC_Cancer_2012_Dec_4_12_570.txt
p.G13D,...vaux H    Association of KRAS p.G13D mutation with outcome i...,417,146,BMC_Cancer_2016_Aug_2_16_585.txt
p.Ala567Thr,c.1699G>A	p.Ala567Thr	rs1803274,41,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp2213Asn,c.6637G>A	p.Asp2213Asn	rs529038,44,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Pro200Leu,c.599C>T	p.Pro200Leu	rs1050450,50,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Arg176Cys,c.526C>T	p.Arg176Cys	rs7412,56,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Cys130Arg,c.388 T>C	p.Cys130Arg	rs429358,59,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp432Glu,c.1296 T>G	p.Asp432Glu	rs7041,62,13,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Thr436Lys,c.1307C>A	p.Thr436Lys	rs4588,65,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Met1Thr,c.2 T>C	p.Met1Thr	rs2228570,68,10,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"...ymorphism of BCHE (c.1699G>A, p.Ala567Thr) was associated wi...",250,189,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"... that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of B...",265,47,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.T972M,"... gene was found, predicting a p.T972M amino acid substitutio...",43,551,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.T972M,"...t with the following primers (p.T972M, For: 5’ -catctttggcag...",85,183,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.T972M,"...e exon 7, namely c.2915C > T, p.T972M (Figure 1) in heterozy...",100,512,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.R605Q,...missense mutations (p.M1? and p.R605Q) of unknown functional...,7,259,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.L398L,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/...,36,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-...,37,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,...l4-homozygous patient and the p.R605Q-heterozygous individua...,47,63,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,"...S16ins3kb, 1638ins23, and the p.R605Q variant (creating a Bs...",47,242,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,...remains to be elucidated. The p.R605Q mutation occurs at a c...,112,450,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.D19H,...ne disease is associated with p.D19H of ABCG8 as well as alt...,4,38,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...ytes. Genotype frequencies of p.D19H were established using ...,7,494,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...lower in individuals carrying p.D19H compared to wild type (...,10,495,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...ive of phenotype, carriers of p.D19H displayed a significant...",10,620,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...rs and controls regardless of p.D19H presence,10,1039,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,Both gallstone disease and p.D19H of ABCG8 are associated...,13,28,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...lesterol absorption. However, p.D19H is not responsible for ...",13,108,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...us carriers of gallstones and p.D19H displayed a higher OR (...,142,881,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...individual; (Gc) = carrier of p.D19H; (GG) = 93 and (Gc) = 2...,158,546,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...d type controls to cases with p.D19H 37%, P = 0.0030). Regar...",160,775,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...= 14; Gc genotype (carrier of p.D19H): C = 18, GS = 11",162,680,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...individual; (Gc) = carrier of p.D19H. Controls: (GG) = 80 an...,166,499,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...ne carriers, with and without p.D19H. Protein content was de...",166,733,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...29]. In our study carriers of p.D19H were characterised by s...,181,503,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.Trp82Arg,...bers of a new family with the p.Trp82Arg ALys variant were r...,7,222,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...all cases and all carried the p.Trp82Arg ALys variant at a h...,7,633,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...yloidosis associated with the p.Trp82Arg lysozyme variant in...,10,44,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...new large family in which the p.Trp82Arg variant (this nomen...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...p://www.hgvs.org/mutnom// and p.Trp82Arg corresponds to the ...,16,1172,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,... from tryptophan to arginine (p.Trp82Arg in the new nomencla...,25,399,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...from tryptophane to arginine. p.Trp82Arg in the new nomencla...,40,429,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...tary ALys associated with the p.Trp82Arg variant is of parti...,66,56,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,The families with the p.Trp82Arg variant already rep...,76,23,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.R163Q,"...other populations, due to the p.R163Q (c.488 G>A) polymorphi...",9,397,BMC_Genet_2008_Apr_10_9_31.txt
p.P18A,p.P18A	c.52 C>G	0	0	0	0	0.08	0...,40,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C35Y,p.C35Y	c.104 G>A	0	0	0	0	0	0.1...,41,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V38M,p.V38M	c.112 G>A	0	0	0	0	0	0.0...,42,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L44V,p.L44V	c.130 C>G	0	0	0	0	0	0.0...,43,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F45L,p.F45L	c.133 T>C	0	0	0	0	0	0.2...,44,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S47I,p.S47I	c.140 G>T	0	0.43	0	0	0	...,45,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L50L,p.L50L	c.150 G>A	0	1.28	0	0	0	...,46,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V60L,p.V60L	c.178 G>T	0.10	0	0	0	10...,47,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	...,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A81P,p.A81P	c.241 G>C	0	0	0	0	0.08	...,49,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83P,p.S83P	c.247 T>C	0	0	0	0	0.15	...,50,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83L,p.S83L	c.248 C>T	0	0	0	0	0	0.0...,51,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D84E,p.D84E	c.252 C>A	0	0	0	0	1.00	...,52,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V92M,p.V92M	c.274 G>A	0.07	0	13.41	...,53,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T95M,p.T95M	c.284 C>T	0	0	0	0	0.08	...,54,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L99I,p.L99I	c.295 C>A	0	0.43	0	0	0	...,55,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A103A,p.A103A	c.309 C>T	0	0.43	0	0	0...,56,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L106Q,p.L106Q	c.317 T>A	0	0	0	0	0	0....,57,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A111V,p.A111V	c.332 C>T	0	0	0	0	0	0....,59,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I120T,p.I120T	c.359 T>C	0	0	1.75	0	0...,60,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122M,p.V122M	c.364 G>A	0	0	0	0	0	0....,61,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122V,p.V122V	c.366 G>C	0	0	0	0	0	0....,62,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R142H,p.R142H	c.425 G>A	0.01	0	0	0	0...,63,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,p.R151C	c. 451 C>T	0.03	0	0	0	...,64,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y152X,p.Y152X	c.456 C>A	0	0	0	0	0	0....,65,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I155T,p.I155T	c.464 T>C	0	0	0	0	0.23...,66,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160W,p.R160W	c.478 C>T	0.04	0	0	0	8...,67,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160Q,p.R160Q	c.479 G>A	0	0	0	0	0	0....,68,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R163Q,p.R163Q	c.488 G>A	0.14	0	75.51...,69,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A166A,p.A166A	c.498 G>A	0	0	0	0	0	0	...,70,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I168I,p.I168I	c.504 C>T	0	0.43	0	0	0...,71,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A171D,p.A171D	c.512 C>A	0	0	0	0	0	0....,72,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V174I,p.V174I	c.520 G>A	0	0	0	0	0.08...,73,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y182Y,p.Y182Y	c.546 C>T	0	0	0	0	0	0	...,74,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F196L,p.F196L	c.586 T>C	0	2.14	0.15	...,75,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R213W,p.R213W	c.637 C>T	0	0	0	0	0	0....,76,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G220G,p.G220G	c.660 C>T	0	0	0	0	0	0....,77,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q228Q,p.Q228Q	c.684 G>A	0	0	0	0	0	0....,78,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230L,p.P230L	c.689 C>T	0	0	0	0	0.31...,79,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230P,p.P230P	c.690 G>A	0	0	0	0	0.08...,80,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q233Q,p.Q233Q	c.699 G>A	0	0	0	0	0	0....,81,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A240A,p.A240A	c.720 T>C	0	0	0	0	0	0	...,82,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T242T,p.T242T	c.726 C>T	0	0	0	0	0	0....,83,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G248V,p.G248V	c.743 G>T	0	0	0	0	0	0....,84,1,BMC_Genet_2008_Apr_10_9_31.txt
p.H260P,p.H260P	c.779 A>C	0	0	0	0	0.23...,85,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I264I,p.I264I	c.792 C>T	0	0	0	0	0.15...,86,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V265V,p.V265V	c.795 C>G	0	1.28	0	0	0...,87,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C273C,p.C273C	c.819 C>T	0	0.43	0	0	0...,88,1,BMC_Genet_2008_Apr_10_9_31.txt
p.K278E,p.K278E	c.832 A>G	0	0	0	0	0.23...,89,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0....,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D294H,p.D294H	c.880 G>C	0.01	0	0	0	1...,91,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F300F,p.F300F	c.900 C>T	0	2.99	0	0	0...,92,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T308M,p.T308M	c.923 C>T	0	0	0	0	0	0....,93,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T314T,p.T314T	c.942 A>G	0.09	44.44	1...,94,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,"... of the T allele of c.451C>T, p.R151C, was 1.9% in Greece bu...",171,673,BMC_Genet_2008_Apr_10_9_31.txt
p.L502V, 	 	c.1504C > G (p.L502V)	9193	31	60	38	1.5	58....,54,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77...,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.V320A,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0.48	9...,62,30,BMC_Genet_2013_Feb_19_14_6.txt
p.M470V,...FTR	NM_000492.3	c.1408 G > A (p.M470V)	9356	30.4	60	38	38.44...,64,32,BMC_Genet_2013_Feb_19_14_6.txt
p.D882G,DMD	NM_004006.2	c.2645A > G (p.D882G)	2974	19.6	5	93	4.98	0...,67,30,BMC_Genet_2013_Feb_19_14_6.txt
p.R1745H, 	 	c.5234 G > A (p.R1745H)	4289	23.4	4	93	93.38...,68,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R2937Q, 	 	c.8810 G > A (p.R2937Q)	3235	20.1	4	94	94.03...,71,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H199R, 	 	c.596A > G (p.H199R)	11616	29.2	9	86	9.13	...,74,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R223H, 	 	c.668 G > A (p.R223H)	10344	31.4	5	93	92.62...,75,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S601L, 	 	c.1802C > T (p.S601L)	6027	21.4	59	34	2.17	...,85,18,BMC_Genet_2013_Feb_19_14_6.txt
p.V780I, 	 	c.2338 G > A (p.V780I)	8957	10.2	11	83	82.93...,90,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.D248N, 	 	c.742 G > A (p.D248N)	15664	32.8	62	35	35.2...,96,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T529M, 	 	c.1586C > T (p.T529M)	15938	25.7	16	78	2.41...,98,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	20556	23.6	2	97	2.13	...,103,18,BMC_Genet_2013_Feb_19_14_6.txt
p.I562T, 	 	c.1685 T > C (p.I562T)	30664	31.2	58	39	1.99...,109,19,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	15648	23	2	96	2.19	1....,112,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R259Q,GALT	NM_000155.2	c.776 G > A (p.R259Q)	27403	31.3	62	32	31.5...,113,31,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68...,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	2864	20.4	62	36	61.91...,116,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L483P, 	 	c.1448 T > C (p.L483P)	3331	26.4	60	38	0.99	...,117,19,BMC_Genet_2013_Feb_19_14_6.txt
p.A495P, 	 	c.1483 G > C (p.A495P)	2569	16.3	53	44	1.01	...,118,19,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	3813	22.9	71	23	70.52...,121,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L62S,HEXB	NM_000521.3	c.185 T > C (p.L62S)	21320	33.2	8	86	3.63	8...,125,31,BMC_Genet_2013_Feb_19_14_6.txt
p.K121R, 	 	c.362A > G (p.K121R)	14201	27.9	66	32	65.6...,126,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R505W, 	 	c.1513C > T (p.R505W)	8306	30.9	62	37	0.52	...,129,18,BMC_Genet_2013_Feb_19_14_6.txt
p.G549R, 	 	c.1645 G > A (p.G549R)	33259	34.6	84	15	15.4...,131,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H33Q,IDUA	NM_000203.3	c.99 T > G / p.H33Q	34	10.2	6	91	2.94	0.00	...,132,31,BMC_Genet_2013_Feb_19_14_6.txt
p.Q70X, 	 	c.208C > T (p.Q70X)	4106	9.4	49	46	2.65	49...,133,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R105Q, 	 	c.314 G > A (p.R105Q)	10809	28.7	62	34	33.7...,135,18,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.T388T, 	 	c.1164 G > C (p.T388T)	3080	23.1	65	31	2.05	...,143,19,BMC_Genet_2013_Feb_19_14_6.txt
p.W402X, 	 	c.1205 G > A (p.W402X)	2679	23.2	62	32	31.88...,144,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S92P, 	 	c.274 T > C (p.S92P)	2505	11.9	14	75	4.79	7...,149,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S246S, 	 	c.738C > T (p.S246S)	10356	27.9	76	24	0.3	...,150,17,BMC_Genet_2013_Feb_19_14_6.txt
p.E267D, 	 	c.801 G > C (p.E267D)	5788	28.6	64	34	0.57	...,151,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R1005Q, 	 	c.3014 G > A (p.R1005Q)	3027	27	50	48	47.9	1...,155,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L1043L, 	 	c.3127 T > C (p.L1043L)	13424	30.6	5	94	0.77...,156,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S298P, 	 	c.892 T > C (p.S298P)	12564	31.7	60	38	0.93...,164,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R456H, 	 	c.1367 G > A (p.R456H)	8525	29.5	61	36	36.29...,165,19,BMC_Genet_2013_Feb_19_14_6.txt
p.V36A, 	 	c.107 T > C (p.V36A)	 	 	 	 	 	 	 	 	 	 ,167,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R695X,ZEB2	NM_014795.3	c.2083C > T (p.R695X)	20800	24.9	75	24	0.51...,169,31,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"..., such as ACADVL c.1504C > G (p.L502V), but also small delet...",237,941,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,... data for ACADVL c.1504C > G (p.L502V) mutation. Panes 1B & ...,241,151,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,... a heterozygous c.1504 C > G (p.L502V) missense mutation in ...,310,156,BMC_Genet_2013_Feb_19_14_6.txt
p.D273Rfs,... a loss-of-function mutation (p.D273RfsX13) in the myostatin...,19,905,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"... in BBC after fixation of the p.D273RfsX13 MSTN allele, and ...",25,149,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...BC. That homozygosity for the p.D273RfsX13 MSTN variant only...,25,306,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...s that are homozygous for the p.D273RfsX13 MSTN mutation (Ad...,25,534,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...of a magnitude similar to the p.D273RfsX13 MSTN mutation? Ar...,27,253,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...mimicking the fixation of the p.D273RfsX13 MSTN mutation pri...,30,216,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"...” BBC (all homozygous for the p.D273RfsX13 MSTN mutation), (...",30,791,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...result of the fixation of the p.D273RfsX13 MSTN variant. Of ...,30,2364,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,... in BBC after fixation of the p.D273RfsX13 MSTN variant arou...,118,132,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,... (i) the fixation of the MSTN p.D273RfsX13 mutation in (old ...,118,576,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.L99P,...(ii) the fixation of the MC1R p.L99P mutation in (old and ne...,118,724,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...lies the fixation of the MSTN p.D273RfsX13 mutation in (old ...,118,1179,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.L99P,...old and new) BBC and the MC1R p.L99P mutation in (old and ne...,118,1235,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...dditive genetic variance (the p.D273RfsX13 MSTN variant has ...,131,299,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...ch are all homozygous for the p.D273RfsX13 MSTN mutation or ...,205,148,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.P19S,"...ssense mutation (rs384285149, p.P19S, Chr1:97,309,054 bp) in...",101,1311,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,The p.P19S (rs384285149) variant i...,103,5,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,...educed lifespan in mice [17]. p.P19S is therefore a plausibl...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,...onfirmed homozygosity for the p.P19S variant in EIF5A2 and f...,119,379,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...3536) is a missense mutation (p.W317R) in SUGT1 encoding SGT...,130,58,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...ality in eukaryotes [24]. The p.W317R-variant is predicted t...,130,354,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...ence. The red arrow indicates p.W317R. Protein sequences wer...,130,719,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.V327I,"...792959, Chr10: 26,948,606 bp, p.V327I). Thirty-eight (out of...",141,828,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,...5A-2. Red color indicates the p.P19S-variant (rs384285149). ...,208,183,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.R961W,"...R) inhibitors; however, a KDR p.R961W c.2881C>T mutation was...",9,1242,Cureus_8(2)_e478.txt
p.R961W,"...) inhibitors, however the KDR p.R961W c.2881C>T mutation tha...",26,712,Cureus_8(2)_e478.txt
p.R961W,... response to regorafenib. KDR p.R961W c.2881C>T mutation has...,50,1091,Cureus_8(2)_e478.txt
p.Gln27Glu,...al relevance of the c.79 C>G (p.Gln27Glu) polymorphism of th...,9,77,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.Gln27Glu,... genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2...,27,34,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.G1706A,"...G, [p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A170...",20,184,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.A1708E,"... > A [p.G1706A], c.5242C > A [p.A1708E], c.589-590delCT [p.S...",20,208,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.S157X,"...A [p.A1708E], c.589-590delCT [p.S157X]; numbered GeneBank U1...",20,235,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.S157X,BRCA1 c.589-590delCT (p.S157X)	F ctcttcaggaggaaaagca...,40,23,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.G1706A,BRCA1 c.5236 G > C (p.G1706A,42,21,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.A1708E,BRCA1 c.5242 C > A (p.A1708E)	F ggacagcacttcctgatt...,43,21,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.E34V,"... and c.670 T>G that result in p.E34V, p.G332A and W224G amin...",12,885,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...70 T>G that result in p.E34V, p.G332A and W224G aminoacid su...",12,893,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,...tion was a missense mutation (p.G232R) and 2 were frameshift...,12,1417,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...6	149	10.40	2411	+/-	c.101A>T/p.E34V,56,46,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,....1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,....5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,....2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,...34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,....3	450	11.77	893	+/+	c.670T>G/p.W224R,70,44,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,...2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,50,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,...35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,....9	0.6	86	120	ND	-/-	c.503G>A/p.R168H,112,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,...	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,42,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.L178V,....0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.H106P,....2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,V	P	18.48	55.58	c.101A>T/p.E34V,197,26,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,D	18.12	54.19	c.670T>G/p.W224R,202,25,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...o a valine residue in exon 3 (p.E34V). The other was a G to ...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,...a alanine residue in exon 10 (p.G332A). The last one was a T...,209,512,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"...an to a glycine substitution (p.W224G) (Proband VIII, Figure...",209,644,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...obable in these cases. In the p.E34V and p.W224G mutations t...,240,640,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,...hese cases. In the p.E34V and p.W224G mutations the glutamic...,240,651,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...X [50] In the other case, the p.G332A mutation, although the...",240,815,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,"...POXs, revealed that mutations p.E34V and p.G332A affect resi...",242,103,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,...led that mutations p.E34V and p.G332A affect residues that a...,242,114,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"The last missense mutation, p.W224G affects a residue whic...",244,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224X,...scribed mutations causing VP: p.W224X [37] and p.W224R [39]....,244,359,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,... causing VP: p.W224X [37] and p.W224R [39]. Recently was als...,244,376,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.I309Sfs,...op codon 5 codons downstream (p.I309Sfs314X). Both mutations...,246,254,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,"... One was a missense mutation, p.G232R [34,35]. The other 2 r...",250,81,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E320Q,"...zygous mutation (c.958G > C, [p.E320Q]) in SLC19A3 was ident...",10,201,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...zygous mutation (c.958G > C, [p.E320Q]) in exon 3 of SLC19A3...",97,93,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...isease mutation (c.958G > C, [p.E320Q]). (A) The sequence an...",99,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...0 for glutamine (c.958G > C, [p.E320Q]), indicated by an arr...",99,283,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...zygous mutation (c.958G > C, [p.E320Q]) in SLC19A3. Our case...",114,330,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.S581Pfs,"...se mutations: (a) c.1740delC (p.S581PfsX40), a cytosine dele...",35,254,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"...on 621; (b) c.2975_2978delAG (p.Q994VfsX6), a deletion of AG...",35,431,BMC_Med_Genet_2010_May_26_11_79.txt
p.D398E,"...sition 1000; (c) c.1194T > A (p.D398E), the consequence of a...",35,612,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,"... in exon 13; (d) c.1780G > A (p.E594K), a transition from G ...",35,784,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,... Apart from c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (...,35,1105,BMC_Med_Genet_2010_May_26_11_79.txt
p.S581Pfs,16	c.1740delC	p.S581PfsX40	Frameshift	050180...,41,15,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,16	c.1780 G > A	p.E594K	Missense	0501768	12	0/...,42,17,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,25	c.2975_2978	p.Q994VfsX6	Frameshift	0400695...,43,16,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,40	c.4819C > T	p.R1607W	Missense	0400695	1	0/...,45,16,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"..., which are c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (...",50,179,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...p.Q994VfsX6) and c.4819C > T (p.R1607W), inherited from the ...",50,209,BMC_Med_Genet_2010_May_26_11_79.txt
p.D398E,"...thogenic variants c.1194T > A/p.D398E, c.1740delC/p.s581PfsX...",52,143,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,...lC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are seque...,52,190,BMC_Med_Genet_2010_May_26_11_79.txt
p.R49W,"...ssense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), ...",54,113,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53T,"...45C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) a...",54,134,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53V,"...57G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C...",54,155,BMC_Med_Genet_2010_May_26_11_79.txt
p.R82C,... > T (p.A53V) and c.244C > T (p.R82C). Some of these polymor...,54,179,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"...ent, namely c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T ...",69,101,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"....Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift muta...",69,132,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,... alleles of c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (...,69,415,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,...p.Q994VfsX6) and c.4819C > T (p.R1607W) were not found in ou...,69,445,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...us mutation of the OTOF gene, p.I515T, was first found in tw...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,...paternally inherited mutation p.R1607W is a missense mutatio...,76,1082,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...W is a missense mutation, and p.R1607W was the consequence o...",76,1119,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,...nt alleles: c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (...,81,359,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,...p.Q994VfsX6) and c.4819C > T (p.R1607W). The special mutatio...,81,389,BMC_Med_Genet_2010_May_26_11_79.txt
p.G908R,"...lso known as CARD15), namely, p.G908R, p.R702W, and p.L1007f...",22,200,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"... as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]...",22,209,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,"... rare non-synonymous variant, p.R381Q, appears to be protect...",22,658,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...5% CI: 1.1-3.2; p = 0.03) for p.R702W, 3.2 (95% CI: 2.2-4.9;...",41,433,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...I: 2.2-4.9; p = 6.4*10-9) for p.G908R, and 5.2 (95% CI: 3.3-...",41,482,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...= 0.17 between rs17221417 and p.G908R and D' = 0.97, r2 = 0....",41,1110,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,...                   	rs2066844	p.R702W	0.02	0.04	1.85 (1.08-3...,52,36,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,rs2066845	p.G908R	0.04	0.11	3.23 (2.15-4...,53,12,BMC_Med_Genet_2011_May_6_12_63.txt
p.T300A,...                   	rs1373692	p.T300A	0.61	0.67	1.29 (1.06-1...,71,36,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,The rare IL23R p.R381Q variant (rs11209026) w...,96,16,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"... AJ individuals [28,29], with p.R702W, pG908R, and p.L1007fs...",158,726,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...ed a slightly higher risk for p.R702W, p.G908R and p.L1007fs...",158,1662,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...htly higher risk for p.R702W, p.G908R and p.L1007fs (OR of 1...",158,1671,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,"...us coding variant rs11209026 (p.R381Q) [16], numerous report...",160,134,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,...r allele at IL23R rs11209026 (p.R381Q) was comparable to tha...,160,366,BMC_Med_Genet_2011_May_6_12_63.txt
p.R2146Q,"...gous mutations, IVS11 + 1 and p.R2146Q, of MYO15A in one (SR...",10,67,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...ariants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were s...",67,187,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,"...15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both ...",67,201,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,... shared by both siblings. The p.S3474G variant was ruled out...,67,245,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2140Q,"...One variant, corresponding to p.R2140Q, was heterozygotic in...",67,545,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mutations, IVS11 + 1G > A and p.R2146Q, are carried by both ...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...), and the other heterozygous p.R2146Q mutation is from the ...",69,411,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...-285 carries the heterozygous p.S2161F mutation in MYO15A, a...",69,496,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Q445R,"...ants of known deafness genes (p.Q445R in GRHL2, p.T1321S in ...",71,66,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.T1321S,"...ness genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161...",71,84,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...GRHL2, p.T1321S in TECTA, and p.S2161F in MYO15A); only one ...",71,107,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...n MYO15A); only one mutation, p.S2161F in MYO15A, was shared...",71,147,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...nother MYO15A coding variant, p.G1220R, which was also share...",71,689,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...ions in MYO15A, IVS11 + 1 and p.R2146Q, were found in the SR...",74,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...while a heterozygous variant, p.S2161F was identified in the...",74,131,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,...e on the arginine side-chain (p.R2146Q). In the other varian...,74,768,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...lar phenylalanine side-chain (p.S2161F). Both alterations ar...,74,887,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,...R-903	Chr17:18049349	c.G6437A	p.R2146Q	Exon 29	MyTH4	0/409	Y...,82,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...R-285	Chr17:18049394	c.C6482T	p.S2161F	Exon 29	MyTH4	0/409	Y...,84,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"Two missense mutations, p.S2161F and p.R2146Q, are loc...",109,25,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...sense mutations, p.S2161F and p.R2146Q, are located in exon ...",109,38,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2124Q,"...VA, it has been reported that p.R2124Q and p.P2073S mutation...",109,760,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.P2073S,...en reported that p.R2124Q and p.P2073S mutations located in ...,109,773,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...entified two novel mutations, p.S2161F and p.R2146Q, which a...",109,1036,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...novel mutations, p.S2161F and p.R2146Q, which are located in...",109,1049,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,... functions of myosin XVA. The p.R2146Q protein contains a pr...,109,1219,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...refore, we speculate that the p.R2146Q mutation cripples the...",109,1637,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...o novel nonsynomous variants, p.G1220R and p.S2161F, in the ...",111,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...nomous variants, p.G1220R and p.S2161F, in the MYO15A gene. ...",111,71,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"..., as the heterozygous variant p.G1220R was present in the Ko...",111,200,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...ly. However, another variant, p.S2161F, was absent in 409 et...",111,395,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,... observed in this family: (1) p.G1220R contributes to the ph...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...earing loss gene. Even though p.S2161F was not the causative...,111,1236,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...ly SR-285, only one mutation, p.S2161F in MYO15A, is shared ...",134,224,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Pro240Leu,"...orted pathological mutations, p.Pro240Leu and p.Glu1595Lys, ...",10,154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...al mutations, p.Pro240Leu and p.Glu1595Lys, as well as one n...",10,170,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...s well as one novel mutation, p.Asn342Ser. The p.Pro240Leu m...",10,215,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...el mutation, p.Asn342Ser. The p.Pro240Leu mutation was found...",10,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"... S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, ...",57,252,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...se mutations, p.Pro240Leu and p.Glu1595Lys, were identified ...",57,268,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...the proband of SR-106 family. p.Pro240Leu was confirmed in t...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...family carried two mutations, p.Pro240Leu and p.Asn342Ser in...",57,625,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...wo mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both...",57,641,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...nd in an affected sibling and p.Pro240Leu was confirmed in t...,57,724,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...patient were heterozygous for p.Pro240Leu (2.15%) and p.Glu1...,57,977,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...s for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respecti...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...ols (over 700). The mutations p.Asn342Ser and p.Glu1595Lys w...,57,1138,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...The mutations p.Asn342Ser and p.Glu1595Lys were absent in al...,57,1154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...e absent in all controls, and p.Pro240Leu was detected in 2 ...",57,1200,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...pound heterozygous mutations, p.Pro240Leu and p.Glu1595Lys, ...",59,216,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...us mutations, p.Pro240Leu and p.Glu1595Lys, were identified....",59,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,... identified. One heterozygous p.Pro240Leu mutation was confi...,59,280,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...pound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, w...",59,385,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...us mutations, p.Pro240Leu and p.Asn342Ser, were carried by a...",59,401,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...ed sibling and a heterozygous p.Pro240Leu mutation by the fa...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,c.C719T	p.Pro240Leu	8	EC3	ㅡ	DAMAGING/0...,75,9,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,c.A1025G	p.Asn342Ser	11	EC3	DXNDN	DAMAG...,76,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,c.G4783A	p.Glu1595Lys	36	EC15	DRE	DAMAG...,77,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...orted pathological mutations, p.Pro240Leu and p.Glu1595Lys, ...",85,97,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...al mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mu...",85,113,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...5Lys, and one novel mutation, p.Asn342Ser (Table 2). The Con...",85,151,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...e threshold of detection. The p.Glu1595Lys mutation reduces ...,85,761,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...d amino acids themselves, the p.Asn342Ser mutation involves ...",85,994,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...impairs protein function like p.Glu1595Lys. The p.Pro240Leu ...,85,1325,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...nction like p.Glu1595Lys. The p.Pro240Leu mutation does not ...,85,1343,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...lexible (Figure 2). Thus, the p.Pro240Leu substitution may a...",85,1631,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...se of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu15...,87,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...t. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are assoc...,87,482,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala361Ser,2	Chr10:73377097	11	c.G1081T	p.Ala361Ser	.	.	1/30	Novel,100,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val424Met,3	Chr10:73405717	12	c.G1270A	p.Val424Met	rs2305207	.	1/30	r...,101,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gly490Ala,5	Chr10:73434888	14	c.G1469C	p.Gly490Ala	rs1227049	8	14/30	...,103,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ser496Asn,6	Chr10:73434906	14	c.G1487A	p.Ser496Asn	rs10999947	7	54/12...,104,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg964Gln,7	Chr10:73464825	24	c.G2891A	p.Arg964Gln2	.	1 (SR-153)	0/12...,105,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1010His,8	Chr10:73466729	25	c.G3029A	p.Arg1010His	.	.	1/30	Novel,106,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gly1118Ser,9	Chr10:73472553	27	c.G3352A	p.Gly1118Ser2	.	1 (SR-931)	0/3...,107,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1335Ala,10	Chr10:73492032	31	c.T4004C	p.Val1335Ala	.	.	1/30	Novel,108,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn1351Asp,11	Chr10:73492079	31	c.A4051G	p.Asn1351Asp	rs1227065	16	29/3...,109,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1437Gln,12	Chr10:73498355	33	c.G4310A	p.Arg1437Gln	rs56181447	5	8/30...,110,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1588Trp,13	Chr10:73501595	36	c.C4762T	p.Arg1588Trp	.	.	1/30	[5],111,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala1575Thr,14	Chr10:73501556	36	c.G4723A	p.Ala1575Thr	rs1227051	16	28/3...,112,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30...,113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1804Gln,16	Chr10:73544086	40	c.G5411A	p.Arg1804Gln	rs3802711	10	16/3...,114,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp1806Glu,17	Chr10:73544093	40	c.C5418G	p.Asp1806Glu	rs74145660	3	6/30...,115,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Thr1999Ser,18	Chr10:73550117	44	c.C5996G	p.Thr1999Ser	rs11592462	6	8/30...,116,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu2044Lys,19	Chr10:73550969	45	c.G6130A	p.Glu2044Lys	rs10466026	12	26/...,117,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val2283Ile,20	Chr10:73558128	48	c.G6847A	p.Val2283Ile3	rs41281334	1 (SR...,118,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2358Gln,21	Chr10:73558886	49	c.G7073A	p.Arg2358Gln	rs4747194	12	26/3...,119,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro2380Leu,22	Chr10:73558952	49	c.C7139T	p.Pro2380Leu	rs4747195	12	26/3...,120,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Met2531Val,23	Chr10:73562763	52	c.A7591G	p.Met2531Val	.	.	1/30	Novel,121,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,24	Chr10:73567365	57	c.T8401G	p.Phe2801Val3	rs3802707	.	2/30...,122,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala3080Thr,25	Chr10:73571307	62	c.G9238A	p.Ala3080Thr	.	1 (SR-1016)	3/1...,123,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe3125Leu,26	Chr10:73571765	64	c.T9373C	p.Phe3125Leu	rs45583140	2	15/3...,124,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tified three CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and...",132,38,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser,...",132,51,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"....Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (15%) of 13 ...",132,69,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tations, including the three (p.Pro240Leu, p.Asn342Ser and p...",132,342,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...uding the three (p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) ...",132,355,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...(p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) detected in the ...",132,371,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg301Gln,"...esent study, and five others (p.Arg301Gln, p.Glu956Lys, p.Ar...",132,433,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu956Lys,"...and five others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.G...",132,446,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1417Trp,"...rs (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, an...",132,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln1716Pro,"...n, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp...",132,473,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2029Trp,"...Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that occur at re...",132,491,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, ...",132,718,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...erozygous for p.Pro240Leu and p.Glu1595Lys, and no other mut...",132,734,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,... other mutation was detected. p.Pro240Leu was reported in Ja...,132,784,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...ndromic hearing loss and that p.Pro240Leu accounted for near...,132,1015,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...y CDH23 mutations carried the p.Pro240Leu mutation and, addi...",132,1189,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...ygous for the mutation. Thus, p.Pro240Leu is the most common...",132,1303,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,... ARNSHL in Asian populations. p.Glu1595Lys was present in 1 ...,132,1389,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) ...",134,677,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...ations, two (p.Glu1595Lys and p.Asn342Ser) affected highly c...",134,694,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ization of CDH23 [15,16]. The p.Glu1595Lys mutation may disr...",134,913,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...6]. Molecular modeling of the p.Glu1595Lys mutation shows im...,134,1147,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...other proteins. Likewise, the p.Asn342Ser mutation is also l...",134,1459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,...t it is a causative mutation. p.Asp428Asn in SR-68 was also ...,136,405,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val2283Ile,...city by segregation analysis. p.Val2283Ile and p.Phe2801Val ...,136,571,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,...on analysis. p.Val2283Ile and p.Phe2801Val were identified a...,136,588,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln778Ser,"... MEFV gene, named c.2330dupG (p.Gln778Serfs*4 or Q778SfsX4) ...",10,105,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Gln778Ser,...STOP to Gly-Ser-Gly-Ala-STOP (p.Gln778Serfs*4 or Q778SfsX4),40,1340,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Ser208Ala,"...lu128_Asn130dup), 606_621dup (p.Ser208Alafs*39) and 761_764d...",89,594,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Asn256Arg,"...Alafs*39) and 761_764dupCCGC (p.Asn256Argfs*70) [1,6,24]. On...",89,632,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Gln778Ser,"...ore, we think the c.2330dupG (p.Gln778Serfs*4) mutation shou...",92,114,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.R5205H,...on 14q. The variant of HMCN1 (p.R5205H) showed the best co-s...,10,398,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.A4704V,"...ally, rare missense variants (p.A4704V, p.T5004I, and p.H524...",10,532,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"... missense variants (p.A4704V, p.T5004I, and p.H5244Q) were d...",10,542,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"...ants (p.A4704V, p.T5004I, and p.H5244Q) were detected in thr...",10,556,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V121I,".... The novel variant (c.G361A, p.V121I) is located in the Con...",144,121,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R5205H,"...iant (rs150188026, c.G15614A, p.R5205H, MAF 0.018) is locate...",144,293,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.A4704V,"...variants in HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T...",144,587,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"...A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15...",144,619,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"...4I, MAF 0.008, and c.C15732G, p.H5244Q, MAF 0.005) (Table 2 ...",144,655,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V393A,"...ing 1 gene (DDHD1) (c.T1178C, p.V393A) and it causes an amin...",144,818,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R168*,c.502C > T	p.R168*	Renal tubular dysgenes...,104,13,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R928C,"c.2782C > T	p.R928C	Bethlem myopathy, #158...",107,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.E1586D,"c.4758A > C	p.E1586D	Alagille syndrome 2, ...",111,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R168*,"...ion within AGTR1 (c.502C > T, p.R168*) would terminate the p...",114,248,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R928C,"...n gene (COL6A3) (c.2782C > T, p.R928C) was identified. Colla...",116,69,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.E1586D,"... NOTCH2 mutation(c.4758A > C, p.E1586D) identified in the in...",118,440,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.Gly243Arg,...red to a homozygous mutation (p.Gly243Arg) in the FBXO32 gen...,11,196,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.His356Tyr,...only two homozygous variants; p.His356Tyr in OC90 and p.Gly2...,64,579,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...ants; p.His356Tyr in OC90 and p.Gly243Arg in FBXO32. The OC9...,64,603,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,"...e at amino acid position 243 (p.Gly243Arg, Fig. 5a). This mi...",64,1368,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.G243R,"...ozygous mutation (c.727G > C, p.G243R) is indicated by the a...",65,40,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...or functional consequences of p.Gly243Ar,71,73,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...he functional consequences of p.Gly243Arg (c.727G > C). The ...,72,150,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...NPs&GO analysis predicted the p.Gly243Arg change as “disease...,72,398,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...on (Fig. 5b). We also modeled p.Gly243Arg of FBXO32 on a tem...,72,834,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...t to the identified mutation (p.Gly243Arg) support the sugge...,91,100,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Phe174Ser,...2881-016-0287-1Case ReportThe p.Phe174Ser mutation is associ...,3,122,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...hogenic mutation (c.724C > T, p.Arg242Cys) and a mutation th...",8,248,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...tuguese patient (c.521 T > C, p.Phe174Ser) whose pathogenici...",8,347,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...the two patients carrying the p.Phe174Ser variant and conclu...,8,449,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...firm the pathogenicity of the p.Phe174Ser variant and we als...,11,317,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...hogenic mutation (c.724C > T, p.Arg242Cys) and a mutation th...",23,142,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...uese population (c.521 T > C, p.Phe174Ser) [11]",23,246,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...f two mutations: c.521 T > C (p.Phe174Ser), inherited from t...",36,438,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...om the mother and c.724C > T (p.Arg242Cys), inherited from t...",36,494,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,... mutations in the DHCR7 gene: p.Arg242Cys and p.Phe174Ser. W...,40,47,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...e DHCR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg2...,40,63,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...s and p.Phe174Ser. Whilst the p.Arg242Cys mutation has been ...,40,87,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ffected by SLOS [14, 15], the p.Phe174Ser has only been repo...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...rams showing the c.521 T > C (p.Phe174Ser), and the c.724C >...",43,42,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...e174Ser), and the c.724C > T (p.Arg242Cys) mutations. b In s...",43,76,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...g the predicted effect of the p.Phe174Ser mutation on the DH...,43,157,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...wo mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cy...,48,530,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,... 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in t...,48,550,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...rtuguese patient carrying the p.Phe174Ser mutation are both ...,48,976,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...our case and the one with the p.Phe174Ser mutation that was ...,48,1139,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...s possible to assume that the p.Phe174Ser variant is associa...,48,1260,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...ures of patients carrying the p.Phe174Ser varian,48,1369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,... clinical significance to the p.Phe174Ser variant and provid...,71,369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg42*,...ence NM_020975.4; NP_009008.2:p.Arg42* indicates that Argini...,40,397,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
p.Gly1349Asp,"...n description syntaxes (e.g. 'p.Gly1349Asp'), reported gene ...",46,180,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
p.S110S,rs1780316	c.330 T > C	p.S110S	1.00	0.94	0.95,79,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Y263H,rs3200254	c.787 T > C	p.Y263H	0.20	0.17	0.11,80,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.P292P,rs3200255	c.876A > G	p.P292P	0.20	0.17	0.11,81,22,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.V522A,rs34605986	c.1565 T > C	p.V522A	0.10	0.00	0.10,82,25,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Arg247Pro,...ons: a novel missense change (p.Arg247Pro) and a well-known ...,7,450,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,...well-known nonsense mutation (p.Glu848*),7,499,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...nine-to-proline substitution (p.Arg247Pro), inherited by the...",28,198,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,... of Glu848 with a stop codon (p.Glu848*) [9]. The healthy br...,28,364,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,...or a novel missense mutation (p.Arg247Pro) and a well-known ...,35,202,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,"...well-known nonsense mutation (p.Glu848*) [9], displayed a mi...",35,251,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,... form. The missense mutation (p.Arg247Pro) within the first ...,35,313,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,"... [17]. The nonsense mutation, p.Glu848*, leading to a trunca...",35,1219,BMC_Nephrol_2014_Mar_3_15_41.txt
p.G2019S,...lation the LRRK2 c.6055G > A; p.G2019S mutation has one of t...,6,204,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...e LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of...",20,617,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...y shown that the c.6055G > A; p.G2019S mutation in LRRK2 is ...,22,47,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,... carry the LRRK2 c.6055G > A; p.G2019S mutation (n = 11). Th...,25,1159,BMC_Neurol_2008_Jan_22_8_1.txt
p.E395X,...ith a homozygous c.1183G > T; p.E395X mutation and a duplica...,45,607,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...ve for the LRRK2 c.6055G > A; p.G2019S mutation, sample S12 ...",67,56,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,... showed that the c.6055G > A; p.G2019S LRRK2 mutation underl...,76,61,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...did not find any c.6055G > A; p.G2019S carriers in the 20 la...,76,190,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,... we did identify c.6055G > A; p.G2019S in 2 of 46 early-onse...,76,281,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...und to carry the c.6055G > A; p.G2019S mutation we calculate...,76,688,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...frequency of the c.6055G > A; p.G2019S is one of the highest...,85,208,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...r R Riess O  Novel homozygous p.E64D mutation in DJ1 in earl...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.Q648X,...of a novel nonsense mutation (p.Q648X) and three previously ...,10,233,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q648X,...ng in a premature stop codon (p.Q648X). In family MCP26 an a...,37,326,BMC_Neurol_2011_Oct_1_11_119.txt
p.Val1314Arg,...odon 50 base pair downstream (p.Val1314ArgfsX18) (Figure 3)....,37,541,BMC_Neurol_2011_Oct_1_11_119.txt
p.Arg438His,...tified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A...,37,647,BMC_Neurol_2011_Oct_1_11_119.txt
p.Asp511Asn,...Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35...,37,679,BMC_Neurol_2011_Oct_1_11_119.txt
p.Val1314Arg,The p.Val1314ArgfsX18 truncating m...,84,5,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q648X,"...oring the truncating mutation p.Q648X, the affected subjects...",84,476,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q78X,...NNB1 (NM_001098209): c.C232T; p.Q78X (Fig. 1B).Fig. 1 Filter...,128,1591,BMC_Neurol_2016_Mar_12_16_35.txt
p.Q78X,...rophoregram with the c.C232T; p.Q78X mutation in exon 3 of C...,128,1765,BMC_Neurol_2016_Mar_12_16_35.txt
p.Q78X,... mutation in CTNNB1 (c.C232T; p.Q78X) which is localized in ...,141,357,BMC_Neurol_2016_Mar_12_16_35.txt
p.R416W,"...ssense mutation, c.1246C > T, p.R416W, despite of no neurolo...",8,834,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,...n at amino acid position 416 (p.R416W). Her daughter’s genom...,48,294,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,...ading to amino acid change in p.R416W (arginine > tryptophan...,48,769,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...n the GFAP gene, c.1246C > T, p.R416W was identified, which ...",53,189,BMC_Neurol_2016_Nov_4_16_211.txt
p.D78N,...omedullary atrophy	c.232G > A	p.D78N,79,65,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,...iventricular rim	c. 274 T > G	p.V87G,80,102,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,...iventricular rim	c. 274 T > G	p.V87G,81,124,BMC_Neurol_2016_Nov_4_16_211.txt
p.R88C,...matter abnormality	c.276C > T	p.R88C,83,49,BMC_Neurol_2016_Nov_4_16_211.txt
p.E205K,... and cervical cord	c.613G > A	p.E205K,84,126,BMC_Neurol_2016_Nov_4_16_211.txt
p.R330G,...atrophy of medulla	c.988C > G	p.R330G,85,75,BMC_Neurol_2016_Nov_4_16_211.txt
p.E332K,c.994G > A	p.E332K,86,12,BMC_Neurol_2016_Nov_4_16_211.txt
p.L331P,...ter and caudates	c.1006 T > C	p.L331P,87,111,BMC_Neurol_2016_Nov_4_16_211.txt
p.N386S,...ta and cerebellar	c.1157A > G	p.N386S,88,103,BMC_Neurol_2016_Nov_4_16_211.txt
p.S398Y,...nd cervical cord	c. 1193C > A	p.S398Y,89,128,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...lla, pons changes	c.1260C > T	p.R416W",91,72,BMC_Neurol_2016_Nov_4_16_211.txt
p.P47L,c.154C > T	p.P47L,92,12,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...f the GFAP gene, c.1246C > T, p.R416W, has been reported to ...",99,408,BMC_Neurol_2016_Nov_4_16_211.txt
p.Ser1218Cys,...le of a premature stop codon (p.Ser1218CysfsX81),65,432,BMC_Psychiatry_2015_May_7_15_107.txt
p.Glu809X,...le of a premature stop codon (p.Glu809X),80,728,BMC_Psychiatry_2015_May_7_15_107.txt
p.Gly12Asp,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; ...,84,23,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Val,...type; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,41,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Ser,...2Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,59,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly13Asp,G13D: p.Gly13Asp,86,7,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,...ample 14 which was actually a p.Gly12Asp (G12D) mutation. Wh...,90,79,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...ible by sequencing indicating p.Gly12Asp mutation, but was n...",90,406,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...eported a mutation in exon 12 p.Gly12Asp, and three labs wer...",92,125,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,...ory #2 found the same result (p.Gly12Asp) in the second set ...,92,478,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Leu1077Pro,...tPhenotypic expression of the p.Leu1077Pro CFTR mutation in ...,3,156,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro CFTR mutation was...,4,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...tabase CFTR2 lead to consider p.Leu1077Pro as a severe CF mu...,4,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...is typical of Southern Italy, p.Leu1077Pro is not included i...",4,272,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...who were heterozygous for the p.Leu1077Pro mutation were inc...,7,106,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...sis Centre, the prevalence of p.Leu1077Pro is 3.6% among all...",9,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,We found that the p.Leu1077Pro CFTR mutation is ...,12,19,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...relatively high prevalence of p.Leu1077Pro associated with t...,12,169,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro (L1077P) mutation...,21,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...rstly found evidence that the p.Leu1077Pro was associated wi...,23,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...is mutation, lead to consider p.Leu1077Pro as a severe CF mu...",25,119,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...ive of a severe CF phenotype, p.Leu1077Pro is not included i...",27,154,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...Sicilian patients bearing the p.Leu1077Pro CFTR mutation fol...,29,114,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...who were heterozygous for the p.Leu1077Pro mutation were inc...,33,431,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,... allele while one carried the p.Asn1303Lys (N1303K) mutation...,33,585,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...nderweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...mal weight)	Birth	p.Phe508del/p.Leu1077Pro	101	155/215,41,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...mal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	...,43,37,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...weight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...formed in our laboratory. The p.Leu1077Pro mutation was iden...,62,541,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...sis Centre, the prevalence of p.Leu1077Pro is 3.6% among all...",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...dy provides evidence that the p.Leu1077Pro is a relatively f...,87,46,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro mutation consists...,89,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"Nevertheless p.Leu1077Pro mutation, althoug...",93,14,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"On this regard, the mutation p.Leu1077Pro is typical of Sou...",97,30,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...ulted pathological. She had a p.Asn1303Lys/p.Leu1077Pro geno...,105,282,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...gical. She had a p.Asn1303Lys/p.Leu1077Pro genotype,105,295,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,"...ation such as p.Phe508del and p.Asn1303Lys, it is clear that...",116,299,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...relatively high prevalence of p.Leu1077Pro associated with t...,118,35,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.I852T,... the same variant c.2555T >C (p.I852T) in the homozygous sta...,57,306,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,...te of the variant c.2555T >C (p.I852T),70,405,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"... 7.4 % of them, with the same p.I852T mutation (of our patie...",72,188,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"...s, especially the c.2555T >C (p.I852T) homozygote variant se...",83,235,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.Arg528Cys,"...ssense mutation, c.1582C > T (p.Arg528Cys), in CACNA1S was d...",7,977,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...minant mutation, c.1582C > T (p.Arg528Cys), in CACNA1S that ...",10,55,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...ion, c.1582C > T, in CACNA1S (p.Arg528Cys) (Figure 1). In hi...",35,394,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...tion in CACNA1S, resulting in p.Arg528Cys. This mutation had...",42,644,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528His,"...h codon of CACNA1S, including p.Arg528His and p.Arg528Gly [5...",42,1032,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Gly,"...1S, including p.Arg528His and p.Arg528Gly [5, 13]. The argin...",42,1048,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...ed a novel dominant mutation, p.Arg528Cys, of CACNA1S causin...",47,157,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg650Cys,...and that showed a c.1948 C>T (p.Arg650Cys) mutation in fibri...,47,87,Cureus_8(5)_e619.txt
p.R206H,...-to-histidine substitution at p.R206H in ALK2 within the GS ...,29,1735,Bone_Res_2015_Apr_14_3_15005.txt
p.L196P,"...utation in the GS domain are: p.L196P, p.P198-F199delinsL, p...",29,2642,Bone_Res_2015_Apr_14_3_15005.txt
p.R202I,"... p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E.70–72 Mor...",29,2671,Bone_Res_2015_Apr_14_3_15005.txt
p.Q207E,"...198-F199delinsL, p.R202I, and p.Q207E.70–72 Moreover, severa...",29,2684,Bone_Res_2015_Apr_14_3_15005.txt
p.R258S,"...eonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W,...",29,2781,Bone_Res_2015_Apr_14_3_15005.txt
p.G325A,"...nase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D,...",29,2790,Bone_Res_2015_Apr_14_3_15005.txt
p.G328E,"...in, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R3...",29,2799,Bone_Res_2015_Apr_14_3_15005.txt
p.G356D,"....R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figu...",29,2812,Bone_Res_2015_Apr_14_3_15005.txt
p.R375P,"...5A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows th...",29,2825,Bone_Res_2015_Apr_14_3_15005.txt
p.Thr52Pro,"...h a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL...",240,149,Bone_Res_2015_Apr_14_3_15005.txt
p.V600E,"...kinase domain of the protein (p.V600E, previously known as p...",17,441,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V599E,"...(p.V600E, previously known as p.V599E; Smalley and Herlyn, 2...",17,470,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...AF gene. The assay can detect p.V600E, p.V600K and p.V600D m...",43,385,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...The assay can detect p.V600E, p.V600K and p.V600D mutations ...",43,394,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600D,"...n detect p.V600E, p.V600K and p.V600D mutations within the B...",43,406,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...wn to be heterozygous for the p.V600E mutation. Human genomi...,49,120,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...wn to be heterozygous for the p.V600E mutation), several ser...",71,60,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...A changes resulting in a BRAF p.V600K alteration, rather tha...",74,521,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"..., rather than the more common p.V600E (g.1799T>A). Sequencin...",74,569,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.N581S,...n this study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601...,74,742,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,...2A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutations w...,74,766,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...nfirmed these mutations to be p.V600E in 42 cases and p.V600...,76,158,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...to be p.V600E in 42 cases and p.V600K in 3 cases. A further ...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,"...sample was shown to harbour a p.K601E mutation, which was no...",76,249,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.Gly12Val,"...r mutations in KRAS codon 12 (p.Gly12Val, heterozygous) and ...",42,204,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...y12Val, heterozygous) and 13 (p.Gly13Asp, heterozygous), res...",42,238,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,... was able to discriminate the p.Gly12Val (H441) and the p.Gl...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA from K...,54,89,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...detect as little as 3% of MUT p.Gly12Val DNA in a WT backgro...,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...wing aberrant melting curves (p.Gly12Val n=2; p.Gly12Asp n=1...,56,808,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,...lting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp ...,56,824,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1),56,843,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...hieved a stable disease had a p.Gly13Asp mutation. The disea...,61,505,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...indicates WT control, and the p.Gly13Asp p.Gly12Val labelled...",83,126,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...T control, and the p.Gly13Asp p.Gly12Val labelled lines indi...",83,137,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...1 cells that harbour the KRAS p.Gly12Val mutation, mixed wit...",85,135,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"... samples (from top to bottom: p.Gly13Asp, p.Gly12Val and the...",87,290,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...om top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp)...",87,302,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"....Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corresponding WT ...",87,321,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...st electropherogram shows the p.Gly13Asp HRMA-mutated sample...,87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"...utated sample, the second the p.Gly12Asp HRMA-mutated sample...",87,523,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...the third and fourth show two p.Gly12Val HRMA-mutated sample...,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly2891Asp,...sense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G sub...,10,374,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"... In the modelling system, the p.Gly2891Asp mutant protein wa...",10,460,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,"...missense mutation, c.7271T>G (p.Val2424Gly), further increas...",21,261,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...wo ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figu...",56,32,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...w translation. The c.8672G>A (p.Gly2891Asp) is a missense mu...,58,444,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncate...,68,452,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...ength ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5...,68,634,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...t was essentially full-length p.Arg3047X (c.9139C>T) (Figure...,68,953,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...iated with the c.1A>G and the p.Gly2891Asp mutant protein ar...,72,257,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...w, although expression of the p.Gly2891Asp mutant protein wa...",72,581,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...tivity in the higher level of p.Gly2891Asp produced when it ...,72,896,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...erminal tags (Figure 6B). The p.Gly2891Asp mutant protein wa...,72,978,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...e was clear evidence that the p.Gly2891Asp mutant protein wa...,74,107,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in p...",77,668,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,...r the ATM mutation c.7271T>G (p.Val2424Gly). The mutation wa...,85,1052,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2716Ala,"... one ATM mutation (c.8147T>C (p.Val2716Ala)), which also has...",87,697,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"... of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G de...",89,313,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...y of the more abundant active p.Gly2891Asp protein, using th...",89,600,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,... could also apply to both the p.Val2424Gly and the p.Val2716...,89,1150,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2716Ala,...both the p.Val2424Gly and the p.Val2716Ala ATM mutations,89,1171,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.His2555Gln,...ull mutation c.7665delinsGTGA;p.His2555Gln ins*) is slightly...,112,564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...ient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant ...,112,702,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...ent A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutan...,112,828,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,....2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of ...,112,1433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,Figure 6 The p.Gly2891Asp protein has resid...,114,14,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...rotein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A,...",114,481,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...t protein (pTAM2, lane 2) and p.Gly2891Asp protein (8672G>A,...",114,747,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...Supplementary Figure 2A). The p.Gly2891Asp (8672G>A) protein...,114,894,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...minal tags. Expression of the p.Gly2891Asp (8672G>A) protein...,114,1225,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...M (pTAM2, lanes 1 and 7). The p.Gly2891Asp (8672G>A) protein...",114,1326,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...s Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein...",114,1550,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.H1047R,GLC82	PIK3CA	p.H1047R	R,128,14,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K,H460	PIK3CA	p.E545K	R,129,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q61H, 	KRAS	p.Q61H	 ,130,8,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12S,A549	KRAS	p.G12S	R,131,11,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q546K, 	PIK3CA	p.Q546K	 ,132,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q61K,H1299	NRAS	p.Q61K	S,133,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT15	KRAS	p.G13D	R,135,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K, 	PIK3CA	p.E545K	 ,136,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12D,LS174T	KRAS	p.G12D	R,137,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.H1047R, 	PIK3CA	p.H1047R	 ,138,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12A,GEO	KRAS	p.G12A	S,139,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW480	KRAS	p.G12V	S,140,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT116	KRAS	p.G13D	S,141,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.H1047R, 	PIK3CA	p.H1047R	 ,142,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW620	KRAS	p.G12V	S,143,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Arg119Ser,"...acids in NSDHL (c.357_358del, p.Arg119Serfs*1d), predicted d...",35,756,Br_J_Dermatol_2015_Jul_28_173(1)_304-307.txt
p.Arg94X,"...ous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control...",77,289,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
p.Ile2047Asn,... one novel missense mutation (p.Ile2047Asn) was analysed in ...,58,46,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,...24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8...,76,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,...3	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.A...,77,44,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,...2)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,71,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,...	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.G...,78,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,...2)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,72,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...4	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln...,79,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,...(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,63,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr1019Met,...3	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.I...,86,44,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2047Asn,...1)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,71,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr1019Met,...	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.G...,87,41,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,...1)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,68,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,...nd moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,46,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1108His,...	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,...	STGD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G...,90,53,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,...98Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,90,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu2027Phe,....150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (fa...,91,47,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,...27Phe	c.5929G>A(43) (false –)	p.Gly1977Ser (false –)	NP,91,84,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg602Trp,...	0.01	0.02	STGD	c.1804C>T(13)	p.Arg602Trp	c.4739delT(33)	p.L...,92,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Pro1486Leu,...	0.01	0.32	STGD	c.4457C>T(30)	p.Pro1486Leu	ND	ND	Yes,93,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg2107His,...6	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val931Met,...2	26	23	NA	STGD	c.2791G>A(19)	p.Val931Met	ND	ND	NP,95,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1640Gln,...5	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.C...,99,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...3)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,70,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,...6	0.05	0.05	CRD	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,100,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr901Ala,...	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...0	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile156Val,...	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,37,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,...37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,39,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly88Gly,3	c.264 A>T	p.Gly88Gly	This study,113,13,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Asn343Asn,8	c.1029T>C	p.Asn343Asn	This study,117,13,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Glu433Glu,10	c.1299A>G	p.Glu433Glu	This study,118,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,12	c.1654G>A	p.Val552Ile	This study,119,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Pro944Pro,19	c.2832A>G	p.Pro944Pro	This study,121,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1169Gln,23	c.3507G>A	p.Gln1169Gln	This study,123,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,"...hree were nonsense mutations (p.Gln234X, p.Gln1315X “de novo...",130,91,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,"...onsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln...",130,102,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,"...34X, p.Gln1315X “de novo” and p.Gln2187X); two splice-site m...",130,127,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,"...ssense changes were detected (p.Ala762Glu, p.Ile2047Asn and ...",130,494,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2047Asn,"...s were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr)...",130,507,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but ...",130,524,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2142Val,...e identified the heterozygous p.Ile2142Val change in one out...,130,640,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"...bed mutations [c.4537delC and p.Trp1724Cys], not included in...",130,870,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"...ning, and one false negative [p.Gly1977Ser] were detected (1...",130,965,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,... one novel change in exon 12 (p.Val552Ile) was found in one ...,134,162,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...tected in this screening, the p.Arg1129Leu mutation was foun...",138,117,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...DM-197, the chip detected the p.Ala1598Asp mutation. However...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"...positive). Interestingly, the p.Trp1724Cys mutation was dete...",147,321,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,...e led to the detection of the p.Gly1977Ser mutation in the p...,147,442,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...sequencing, a false positive [p.Ala1598Asp] was identified. ...",150,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"..., both patients presented the p.Gly1961Glu mutation, which i...",154,663,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,The p.Arg1129Leu mutation was foun...,167,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...f the Spanish population, the p.Arg1129Leu variant was ident...",167,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"..., double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr ...",167,624,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...gous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who pres...",167,641,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...esented a CRD phenotype. This p.Cys2137Tyr change was locate...,167,699,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...rlier onset of disease.16 The p.Cys2137Tyr change in combina...,167,962,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...hange in combination with the p.Arg1129Leu allele produced a...,167,1006,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"..., we speculate that the novel p.Cys2137Tyr variant could be ...",167,1091,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...disease-associated allele was p.Gly1961Glu (3/62; 4.8%), pre...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,"...null mutation (c.1030insT and p.Gln2187X), who presented sym...",169,280,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...ect a moderate effect for the p.Gly1961Glu allele, as previo...",169,392,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg212Cys,"...ygous for the c.3211insGT and p.Arg212Cys variants, showing ...",171,1262,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,"...y, we identified the missense p.Val1433Ile mutation, located...",179,104,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile156Val,"...enotyping microarray, and the p.Ile156Val allele was detecte...",181,77,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,"....24 So many variants, such as p.Val552Ile, could be really a...",191,184,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.R402C,"...sic lissencephaly have either p.R402C mutations, resulting i...",62,727,Brain_2012_May_16_135(5)_1348-1369.txt
p.R402H,"...a with a cell-sparse zone, or p.R402H mutations, resulting i...",62,827,Brain_2012_May_16_135(5)_1348-1369.txt
p.Val374Rfs,...plication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 dupl...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Val374Rfs,...plication; c.836-?_1119+?dup; p.Val374Rfs*8,103,128,Brain_2013_Jan_3_136(1)_269-281.txt
p.Pro149Leu,"...55759 T>A, c.446 C>T, causing p.Pro149Leu, which is located ...",116,371,Brain_2013_Jan_3_136(1)_269-281.txt
p.Gln215*,"...chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exome seq...",116,447,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg395*,"...chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozygous i...",116,590,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg126His,"...which is c.377G>A, leading to p.Arg126His. Interestingly, th...",116,881,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg395*,...ing to c.1183 A>T and causing p.Arg395*. The second compound...,121,132,Brain_2013_Jan_3_136(1)_269-281.txt
p.Ala53Thr,...encing to be c.157G>A causing p.Ala53Thr located in exon 1. ...,121,239,Brain_2013_Jan_3_136(1)_269-281.txt
p.Tyr226Cys,... mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous...,123,639,Brain_2013_Jan_3_136(1)_269-281.txt
p.Glu396*,...as a homozygous stop mutation p.Glu396* has been reported to...,132,2263,Brain_2013_Jan_3_136(1)_269-281.txt
p.R95H,...c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice err...,47,58,Brain_2014_May_18_137(5)_1350-1360.txt
p.E50K,....[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice errors a (P)	30 ...,47,71,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,...5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann e...,48,34,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"....[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 20...",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,...y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Novel...,49,36,Brain_2014_May_18_137(5)_1350-1360.txt
